METTL3 and acute myeloid leukemia: The result shows sustained degradation of METTL3 in MOLM13 and MV4.11 AML cell lines treated with ZW27941 compared with DMSO control, validating the prolonged efficacy of the PROTAC treatment observed in the colony-forming unit assays.